期刊文献+

免疫组织化学和免疫印迹法诊断dystrophin相关的临床表现良性肌病 被引量:2

Immunohistochemistry and dystrophin WU Dong-yan, LIU Zhi, QIAN Min, GUO Academy of Medical Sciences, Western blot for diagnosis of benign muscular dystrophy related with
原文传递
导出
摘要 目的探讨免疫组织化学(immunohistochemistry,IHC)和免疫印迹(Westernblot)法在诊断dystrophin表达异常的临床表现相对良性肌病中的价值。方法收集4例肌肉活体组织检查标本显示dystrophin表达异常、临床表现良性的肌病患者的病史、临床特点,并对肌肉组织标本分别行组织学、IHC(dys—N、dys—R及dys—C)染色,同时进行Western blot分析。结果4例患者中2例主要表现为肢体无力,另2例主要表现为单纯的肌肉疼痛和血清CK升高。组织学显示2例为明显肌源性改变,可见肌纤维萎缩、肥大及分裂现象,另2例仅见肌纤维轻度大小不等。IHC发现1例患者肌纤维膜dys—N无表达,dys—R及dys—C显示肌纤维膜清晰着色,Westernblot示dys—R及dys-C条带较健康对照淡,dys—N条带完全缺失;3例IHC显示患者dys—R无表达,ays—N及dys—C显示肌纤维膜清晰着色,其中2例Western blot示dys—R条带完全缺失,dys-C及dys—N条带相对分子质量改变。结论利用3种抗dystrophin抗体进行肌肉组织IHC标记可以减少漏诊,Western blot对进一步确定dystrophin蛋白异常类型是十分必要的。 Objective To investigate the value of the immunohistochemistry and Western blot in the diagnosis of the benign muscular dystrophy with abnormal dystrophin expression. Methods The medical histories and clinical manifestations of 4 patients were collected. In addition to routine histological and histochemical studies, expression of dystrophin in muscle fibers was observed by immunohistochemical reaction (dys-N, dys-R and dys-C ) and Western blot to anti-dystrophin antibody. Results Two patients had muscular weakness while another 2 patients had only muscular pain and elevated creatine kinase blood levels without muscular weakness. Histochemical stains showed atrophy, hypertrophy and fiber splitting in 2 patients, while only variation in fiber size was presented in another 2 patients. One patient bad no reaction for dys-N, but had immunostains for dys-C and dys-R in the sarcolemma of muscle fibers. Western blot confirmed that the band of dys-C and dys-R was partly deficient, and the band of dys-N was absent compared with control. Three patients had no reaction for dys-R, but had immunostains for dys-C and dys-N. Compared with control, Western blot confirmed that the band of dys-R was absent, and the band of dys-C and dys-N were truncated. Conclusion The immunohistochemistry is stained with three anti-dystrophin antibodies to avoid diagnostic errors. Western blot is essential to further determine the type of dystrophin protein.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2010年第1期45-50,共6页 Chinese Journal of Neurology
关键词 肌疾病 肌营养不良蛋白 免疫组织化学 印迹法 蛋白质 Muscular diseases Dystrophin Immunohistochemistry Blotting western
  • 相关文献

参考文献9

  • 1陈琳.运用免疫组织化学方法协助诊断肌营养不良[J].中华神经科杂志,2007,40(12):793-795. 被引量:4
  • 2Filosto M, Tonin P, Vattemi G, et al. The role of muscle biopsy in investigating isolated muscle pain. Neurology, 2007, 68 : 181- 186.
  • 3Sanchez-Arjona MB, Rodrtguez-Uranga JJ, Giles-Lima M, et al. Spanish family with myalgia and cramps syndrome. J Neurol Nearosurg Psychiatry, 2005, 76: 286-289.
  • 4Ceulemans BP, Storm K, Reyniers E Jr, et al. Muscle pain as the only presenting symptom in a girl with dystrophinopathy. Pediatr Neurol, 2008, 38: 64-66.
  • 5Comi GP, Prelle A, Bresolin N, et al. Clinical variability in Becker muscular dystrophy. Genetic, biochemical and immunohistochemical correlates. Brain, 1994, 117 ( Pt 1 ) : 1-14.
  • 6Muntoni F, Torelli S, Ferlini A. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol, 2003, 2 : 731o740.
  • 7Beggs AH, Hoffman EP, Snyder JR, et al. Exploring the molecular basis for variability among patients with Becker muscular dystrophy : dystrophin gene and protein studies. Am J Hum Genet, 1991,49: 54-67.
  • 8Matsumura K, Burghes AH, Mora M, et al analysis of dystrophin-assoeiated proteins in Becker/Dueherme muscular dystrophy with huge in-frame deletions in the NH2- terminal and rod domains of dystrophin. J Clin Invest, 1994, 93 : 99-105.
  • 9Smythe G, Winder SJ, Rondo TA. The functional biology ol dystrophin: associated signaling pathways and potential targets for therapeutic intervention//Chamberlain JS, Rando TA. Ducherme muscular dystrophy: advances in therapeutics. New York: Taylor & Francis Group, 2006 : 55-76.

二级参考文献11

共引文献3

同被引文献31

  • 1Song TJ,Lee KA,Kang SW. Three cases of manifesting female carriers in patients with Duchenne muscular dystrophy[J].YONSEI MEDICAL Journal,2011.192-195.
  • 2Seemann N,Selby K,McAdam L. Symptomatic dystrophinopathies in female children[J].Neuromuscular Disorders,2011.172-177.
  • 3Golla S,Agadi S,Bums DK. Dystrophinopathy in girls with limb girdle muscular dystrophy phenotype[J].J Clin Neuromuscul Dis,2010.203-208.
  • 4Soltanzadeh P,Friez M J,Dunn D. Clinical and genetic characterization of manifesting carriers of DMD mutations[J].Neuromuscular Disorders,2010.499-504.
  • 5Wang X,Wang Z,Yan M. Similarity of DMD gene deletion and duplication in the Chinese patients compared to global populations[J].Behavioral and Brain Functions,2008.20.
  • 6Yoon J,Kim SH,Ki CS. Carrier woman of Duchenne muscular dystrophy mimicking inflammatory myositis[J].Journal of Korean Medical Science,2011.587-591.
  • 7Tunteeratum A,Witoonpanich R,Phudhichareonrat S. Congestive heart failure with rhabdomyolysis and acute renal failure in a manifesting female carrier of Duchenne muscular dystrophy with duplication of dystrophin gene[J].J Clin Neuromuscul Dis,2009.49-53.
  • 8Fujii K,Minami N,Hayashi Y. Homozygous female Becker muscular dystrophy[J].American Journal of Medicdl Genetics,2009.1052-1055.
  • 9Anand A,Vinish M,Prabhakar S. A case of manifesting carrier with DMD phenotype[J].Acta Medica(Hradec Kralove),2009.167-170.
  • 10Schanzer A,Rau I,Kress W. Duchenne muscular dystrophy in a 4-year-old girl due to heterozygous frame shift deletion of the dystrophin gene and skewed X-inactivation[J].KLINISCHE PADIATRIE,2012.256-258.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部